Skip to content

MEDLINE DYNDH1699Recalls & reported problems

Medline Industries, Inc. · BIOPSY PACK · Class 1

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10653160349914), received between Feb 10, 2023 and Feb 10, 2023.

The most frequently reported specific device problem is “Crack” (1 report).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. May 21, 2026Class IIOpen, Classified

    The kits containing Huons Lidocaine HCL Injection USP 1% 10mg/ml 5mL Ampules (Lidocaine Ampules)(OEM). A recall notice was issued by Huons Co., Ltd. for Lidocaine Ampules due to quality issues identified during a recent FDA manufacturing inspection of its drug manufacturing site.

    Z-2542-2026 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗

Most reported problems

Device problems

  • Crack1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • No answer providedFeb 10, 2023Crack

    A CRACKED SPECIMEN VIAL FOUND IN ULTRASOUND BIOPSY KIT. VIAL REMOVED, NO HARM OR DELAY TO PATIENT CARE.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16351088 ↗

Other TRAY, SURGICAL devices

All TRAY, SURGICAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page